BCPC
Balchem Corporation
Is BCPC Halal?
Human-nutrition, animal-nutrition and specialty-ingredient manufacturing — generally permissible activity whose known current asset-based ratios pass, with gross interest income and activity classification incomplete.
What You Should Know
Balchem's March 31, 2026 Form 10-Q reports assets of $1,693.742 million, conservative debt of $192.346 million including its revolving loan, other long-term obligations and finance leases, cash of $72.873 million, receivables of $154.232 million and quarterly revenue of $270.709 million. Debt/assets is 11.36%, liquidity/assets is 4.30% and receivables plus cash/assets is 13.41%; known asset-based ratios pass, but gross interest income and a universal prohibited-revenue numerator are not separately disclosed.
⚠️ Concerns
- •Known asset-based ratios pass, but gross interest income and activity classification remain incomplete
- •Revolving-loan and acquisition activity
- •Human and animal nutrition and industrial end markets
- •Commodity, regulatory and customer-concentration exposure
- •No universal prohibited-revenue numerator is disclosed
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-15.
192.346 / 1,693.742
72.873 / 1,693.742
227.105 / 1,693.742
- Financial
- Incomplete
- Overall
- Incomplete
Debt/assets is 11.36%, liquidity/assets is 4.30% and receivables-plus-cash/assets is 13.41%; gross interest income and activity remain unavailable.
- Financial
- Pass
- Overall
- Incomplete
Known debt, liquidity and receivables-plus-cash ratios are below the examined MSCI limits; this is not an index-membership claim and activity remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt/assets and identifiable liquidity/assets are below the examined Malaysia limits; this is a calculation against SAC ratios, not an official classification.
- Financial
- Not calculated
- Overall
- Incomplete
A licensed historical market-cap series is not stored; filing-based asset ratios remain documented.
Business-activity disclosure
Balchem manufactures specialty ingredients for human nutrition, animal nutrition, health and wellness, and industrial applications. The core ingredient and manufacturing activity is generally permissible, but the filing does not provide a universal prohibited-revenue numerator for product or customer end uses.
Limitation: No universal prohibited-activity revenue numerator or scholar-specific purification percentage is disclosed; nutrition, animal-use and industrial end-use allocation remains qualitative.
Purification
The filing does not separately disclose gross interest income; ZakatInvest does not infer a purification amount or prescribe a fixed scholar-approved percentage.
Inputs, assumptions and primary sources
- Amounts are USD millions from Balchem's March 31, 2026 Form 10-Q.
- Conservative debt combines the $169.000 million revolving loan, $21.647 million of other long-term obligations and $1.699 million of finance-lease liabilities; operating leases are excluded.
- Cash and cash equivalents are $72.873 million and net accounts receivable are $154.232 million; no separate interest-bearing securities balance is identified.
- First-quarter revenue is $270.709 million. The filing reports net interest expense of $2.213 million, not a gross interest-income numerator.
- Nutrition, chelation and specialty-ingredient manufacturing is retained as qualitative analysis; no universal prohibited-revenue numerator is disclosed.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →